Abstract
Symptomatic calcific aortic stenosis is associated with poor quality of life and low survival rates unless corrected surgically. However, a large number of these patients suffer from much comorbidity.
In the past, there was no acceptable clinical solution for these patients and balloon aortic valvuloplasty was considered as a method associated with a high procedural risk and minimal clinical effect. Based on the new information, aortic valvuloplasty strategies should be re-evaluated, because the increasing numbers of poor surgical candidates require less invasive therapeutical methods such as balloon aortic valvuloplasty that is able to improve quality of life.